NCT00545935View on ClinicalTrials.gov

Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso

PHASE2CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

October 31, 2007

Conditions
Malaria
Interventions
DRUG

Methylenblue-Amodiaquine (MB-AQ)

For 3 days twice daily 10 mg/kg MB accompanied by once daily 10 mg/kg AQ

DRUG

Methylenblue-Artesunate (MB-AS)

3 days once daily 4 mg/kg AS accompanied by twice daily 10 mg/kg MB given over 7 days

DRUG

Artesunate-Amodiaquine (AS-AQ)

For 3 days once daily 10 mg/kg AQ accompanied by 4mg/kg AS.

Trial Locations (1)

Unknown

Centre de Recherche en Sante de Nouna, Nouna

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT00545935 - Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso | Biotech Hunter | Biotech Hunter